Tetraphase has two suitors, despite struggling market for antibiotics
The market for antibiotics may be “broken,” but one small antibiotic company is seemingly in demand: Tetraphase Pharmaceuticals. In March, the company said it had …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
